Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company is seeking a Director, Medical Science Liaison, Oncology to join their team. The ideal candidate will be responsible for cultivating and strengthening professional relationships with key opinion leaders, healthcare providers, and academic centers of excellence involved in various phases of product development.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.